Company: BIAF
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023405
Chunk: 24

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 24
---
469,596 

    Finance leases: 
    September 30, 2025  
    December 31, 2024 
  
    Finance lease right-of-use asset, gross 
    $565,030  
    $1,294,168 
  
    Accumulated amortization 
     (451,477) 
     (513,296)
  
    Finance lease right-of-use asset, net 
    $113,553  
    $780,872 
  
    Finance lease liability, current portion 
    $123,757  
    $395,301 
  
    Finance lease liability, long-term 
     1,998  
     444,448 
  
    Total finance lease liabilities 
    $125,755  
    $839,749 

    Weighted-average remaining lease term: 
    September 30, 2025  
    December 31, 2024 
  
    Operating leases (in years) 
     3.22  
     4.21 
  
    Finance leases (in years) 
     0.64  
     2.39 

    Weighted-average discount rate: 
    September 30, 2025  
    December 31, 2024 
  
    Operating leases 
     7.32% 
     7.41%
  
    Finance leases 
     7.85% 
     8.03%

Future
minimum lease payments under non-cancellable leases as of September 30, 2025, are as follows:

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT UNDER NON-CANCELLABLE

    Operating Leases  
    Finance
                                                                                Leases 
  
    Remaining for 2025 
    $39,696  
    $61,384 
  
    2026 
     159,282  
     67,425 
  
    2027 
     110,063  
     — 
  
    2028 
     40,616  
     — 
  
    2029 
     42,252  
     — 
  
    2030 and thereafter 
     28,919  
     — 
  
    Total undiscounted cash flows 
     420,828  
     128,809 
  
    Less discounting 
     (45,689) 
     (3,054)